"Do you think Frosty knows 1 or 2 things about Mesoblast ?"
I'm sure "Frosty" knows not just 1 or 2 things, but 100 or 200 things or even 1,000 or 2,000 things, about Mesoblast.
Are you suggesting, though, that he is sharing some of Teva's strategic intentions - those that he would have become privy to during his tenure in Teva's inner sanctum, but which are not in the public domain - with an individual equity analyst?
And that it is that information which forms the basis of the analyst's view of Teva's strategic intent in relation to Mesoblast?
If not, then I'm not sure of the relevance of the link you are making between chairman and analyst.
Trading high volume, page-149
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.57 |
Change
-0.210(11.8%) |
Mkt cap ! $1.792B | |||
| Open | High | Low | Value | Volume |
| $1.72 | $1.74 | $1.52 | $15.63M | 9.716M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5127 | $1.57 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.57 | 39613 | 3 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |